These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35844027)

  • 1. X-linked myotubular myopathy is associated with epigenetic alterations and is ameliorated by HDAC inhibition.
    Volpatti JR; Ghahramani-Seno MM; Mansat M; Sabha N; Sarikaya E; Goodman SJ; Chater-Diehl E; Celik A; Pannia E; Froment C; Combes-Soia L; Maani N; Yuki KE; Chicanne G; Uusküla-Reimand L; Monis S; Alvi SA; Genetti CA; Payrastre B; Beggs AH; Bonnemann CG; Muntoni F; Wilson MD; Weksberg R; Viaud J; Dowling JJ
    Acta Neuropathol; 2022 Sep; 144(3):537-563. PubMed ID: 35844027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous Administration of a MTMR2-Encoding AAV Vector Ameliorates the Phenotype of Myotubular Myopathy in Mice.
    Danièle N; Moal C; Julien L; Marinello M; Jamet T; Martin S; Vignaud A; Lawlor MW; Buj-Bello A
    J Neuropathol Exp Neurol; 2018 Apr; 77(4):282-295. PubMed ID: 29408998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Mtm1 causes cholestatic liver disease in a model of X-linked myotubular myopathy.
    Karolczak S; Deshwar AR; Aristegui E; Kamath BM; Lawlor MW; Andreoletti G; Volpatti J; Ellis JL; Yin C; Dowling JJ
    J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37490339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular, biochemical and molecular changes in muscles from patients with X-linked myotubular myopathy due to MTM1 mutations.
    Bachmann C; Jungbluth H; Muntoni F; Manzur AY; Zorzato F; Treves S
    Hum Mol Genet; 2017 Jan; 26(2):320-332. PubMed ID: 28007904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen prolongs survival and alleviates symptoms in mice with fatal X-linked myotubular myopathy.
    Gayi E; Neff LA; Massana Muñoz X; Ismail HM; Sierra M; Mercier T; Décosterd LA; Laporte J; Cowling BS; Dorchies OM; Scapozza L
    Nat Commun; 2018 Nov; 9(1):4848. PubMed ID: 30451843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis.
    Buj-Bello A; Fougerousse F; Schwab Y; Messaddeq N; Spehner D; Pierson CR; Durand M; Kretz C; Danos O; Douar AM; Beggs AH; Schultz P; Montus M; Denèfle P; Mandel JL
    Hum Mol Genet; 2008 Jul; 17(14):2132-43. PubMed ID: 18434328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific Mtm1 mutagenesis by an AAV-Cre vector reveals that myotubularin is essential in adult muscle.
    Joubert R; Vignaud A; Le M; Moal C; Messaddeq N; Buj-Bello A
    Hum Mol Genet; 2013 May; 22(9):1856-66. PubMed ID: 23390130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues.
    Biancalana V; Scheidecker S; Miguet M; Laquerrière A; Romero NB; Stojkovic T; Abath Neto O; Mercier S; Voermans N; Tanner L; Rogers C; Ollagnon-Roman E; Roper H; Boutte C; Ben-Shachar S; Lornage X; Vasli N; Schaefer E; Laforet P; Pouget J; Moerman A; Pasquier L; Marcorelle P; Magot A; Küsters B; Streichenberger N; Tranchant C; Dondaine N; Schneider R; Gasnier C; Calmels N; Kremer V; Nguyen K; Perrier J; Kamsteeg EJ; Carlier P; Carlier RY; Thompson J; Boland A; Deleuze JF; Fardeau M; Zanoteli E; Eymard B; Laporte J
    Acta Neuropathol; 2017 Dec; 134(6):889-904. PubMed ID: 28685322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the neuropathy-associated MTMR2 gene rescues MTM1-associated myopathy.
    Raess MA; Cowling BS; Bertazzi DL; Kretz C; Rinaldi B; Xuereb JM; Kessler P; Romero NB; Payrastre B; Friant S; Laporte J
    Hum Mol Genet; 2017 Oct; 26(19):3736-3748. PubMed ID: 28934386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype.
    Pierson CR; Dulin-Smith AN; Durban AN; Marshall ML; Marshall JT; Snyder AD; Naiyer N; Gladman JT; Chandler DS; Lawlor MW; Buj-Bello A; Dowling JJ; Beggs AH
    Hum Mol Genet; 2012 Feb; 21(4):811-25. PubMed ID: 22068590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic heterozygous X-Linked myotubular myopathy female patient with a large deletion at Xq28 and decrease expression of normal allele.
    Gómez-González C; Rosas-Alonso R; Rodríguez-Antolín C; García-Guede A; Ibáñez de Caceres I; Sanguino J; Pascual SI; Esteban I; Pozo AD; Mori MÁ; Torres RJ; Prior C
    Eur J Med Genet; 2021 Apr; 64(4):104170. PubMed ID: 33618039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of a mouse model of X-linked myotubular myopathy.
    Sarikaya E; Sabha N; Volpatti J; Pannia E; Maani N; Gonorazky HD; Celik A; Liang Y; Onofre-Oliveira P; Dowling JJ
    Dis Model Mech; 2022 Jul; 15(7):. PubMed ID: 35694952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of catalytically inactive lipid phosphatase myotubularin-related protein 12 impairs myotubularin stability and promotes centronuclear myopathy in zebrafish.
    Gupta VA; Hnia K; Smith LL; Gundry SR; McIntire JE; Shimazu J; Bass JR; Talbot EA; Amoasii L; Goldman NE; Laporte J; Beggs AH
    PLoS Genet; 2013 Jun; 9(6):e1003583. PubMed ID: 23818870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large duplication in MTM1 associated with myotubular myopathy.
    Amburgey K; Lawlor MW; Del Gaudio D; Cheng YW; Fitzpatrick C; Minor A; Li X; Aughton D; Das S; Beggs AH; Dowling JJ
    Neuromuscul Disord; 2013 Mar; 23(3):214-8. PubMed ID: 23273872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatase-dead myotubularin ameliorates X-linked centronuclear myopathy phenotypes in mice.
    Amoasii L; Bertazzi DL; Tronchère H; Hnia K; Chicanne G; Rinaldi B; Cowling BS; Ferry A; Klaholz B; Payrastre B; Laporte J; Friant S
    PLoS Genet; 2012; 8(10):e1002965. PubMed ID: 23071445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. rAAV-related therapy fully rescues myonuclear and myofilament function in X-linked myotubular myopathy.
    Ross JA; Tasfaout H; Levy Y; Morgan J; Cowling BS; Laporte J; Zanoteli E; Romero NB; Lowe DA; Jungbluth H; Lawlor MW; Mack DL; Ochala J
    Acta Neuropathol Commun; 2020 Oct; 8(1):167. PubMed ID: 33076971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential muscle hypertrophy is associated with satellite cell numbers and Akt pathway activation following activin type IIB receptor inhibition in Mtm1 p.R69C mice.
    Lawlor MW; Viola MG; Meng H; Edelstein RV; Liu F; Yan K; Luna EJ; Lerch-Gaggl A; Hoffmann RG; Pierson CR; Buj-Bello A; Lachey JL; Pearsall S; Yang L; Hillard CJ; Beggs AH
    Am J Pathol; 2014 Jun; 184(6):1831-42. PubMed ID: 24726641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Necklace" fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy.
    Bevilacqua JA; Bitoun M; Biancalana V; Oldfors A; Stoltenburg G; Claeys KG; Lacène E; Brochier G; Manéré L; Laforêt P; Eymard B; Guicheney P; Fardeau M; Romero NB
    Acta Neuropathol; 2009 Mar; 117(3):283-91. PubMed ID: 19084976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of myotubularin (MTM1) leads to muscle hypotrophy through unbalanced regulation of the autophagy and ubiquitin-proteasome pathways.
    Al-Qusairi L; Prokic I; Amoasii L; Kretz C; Messaddeq N; Mandel JL; Laporte J
    FASEB J; 2013 Aug; 27(8):3384-94. PubMed ID: 23695157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-linked myotubular myopathy in a family with two infant siblings: a case with MTM1 mutation.
    Jeon JH; Namgung R; Park MS; Park KI; Lee C; Lee JS; Kim SH
    Yonsei Med J; 2011 May; 52(3):547-50. PubMed ID: 21488203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.